Botanical species · safety record

Tylophora indica

The EFSA Compendium of Botanicals holds 5 constituent measurements for Tylophora indica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Tylophora indica (Burm. f.) Merr.

5Constituent measurements

0Safety records

5Cited sources

4Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 4 licensed products naming Tylophora indica as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Leaf

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Unspecified	Solvent extraction	—	Unspecified	Resolve DOI
Alkaloids	Aerial part of plants	Solvent extraction	0.52 Percent	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Alkaloids	Leaves	Solvent extraction	0.41 Percent	Unspecified	Resolve DOI
Alkaloids	Aerial part of plants	Solvent extraction	—	Unspecified	Resolve DOI
Saponins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Gujrati, Vipul., Patel, Nilesh., Rao, Venkat N., Nandakumar, K., Gouda, T. S., Shalam, Md., Kumar, S. M. Shanta. Hepatoprotective activity of alcoholic and aqueous extracts of leaves of Tylophora indica (Linn.) in rats . Indian journal of pharmacology, 2007, vol. 39, no. 1, p. 43-47.
Ganguly, T., Khar, A. Induction of apoptosis in a human erythroleukemic cell line K562 by Tylophora alkaloids involves release of cytochrome c and activation of caspase 3 . Phytomedicine, 2002, vol. 9, no. 4, p. 288-295. DOI
ALI, M., ANSARI, SH., QADRY, JS. RARE PHENANTHROINDOLIZIDINE ALKALOIDS AND A SUBSTITUTED PHENANTHRENE, TYLOINDANE, FROM TYLOPHORA-INDICA . Journal of natural products, 1991, vol. 54, no. 5, p. 1271-1278. DOI
Kathuria, Vanit., Kaushik, Nutan. Feeding inhibition of Helicoverpa armigera (Hubner) by Eucalyptus camaidulensis and Tylophora indica extracts . Insect science, 2005, vol. 12, no. 4, p. 249-254. DOI
BHUTANI, KK., SHARMA, GL., ALI, M. PLANT BASED ANTIAMOEBIC DRUGS .1. ANTIAMOEBIC ACTIVITY OF PHENANTHROINDOLIZIDINE ALKALOIDS - COMMON STRUCTURAL DETERMINANTS OF ACTIVITY WITH EMETINE . Planta medica, 1987, vol. 53, no. 6, p. 532-536. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature